Trial Profile
Study of mechanism of neurofibrillary tangle (NFT) formations affecting cognitive domain across Alzheimer's Disease Spectrum
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Diagnostic use
- 03 Oct 2018 New trial record